AU3635695A - Methods for genetically modifying hematopoietic stem cells - Google Patents

Methods for genetically modifying hematopoietic stem cells

Info

Publication number
AU3635695A
AU3635695A AU36356/95A AU3635695A AU3635695A AU 3635695 A AU3635695 A AU 3635695A AU 36356/95 A AU36356/95 A AU 36356/95A AU 3635695 A AU3635695 A AU 3635695A AU 3635695 A AU3635695 A AU 3635695A
Authority
AU
Australia
Prior art keywords
methods
stem cells
hematopoietic stem
genetically modifying
modifying hematopoietic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU36356/95A
Inventor
William G Kerr
James J Mule
Garry P Nolan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Systemix Inc
Leland Stanford Junior University
Original Assignee
Systemix Inc
Leland Stanford Junior University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Systemix Inc, Leland Stanford Junior University filed Critical Systemix Inc
Publication of AU3635695A publication Critical patent/AU3635695A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20211—Vesiculovirus, e.g. vesicular stomatitis Indiana virus
    • C12N2760/20222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU36356/95A 1994-09-19 1995-09-18 Methods for genetically modifying hematopoietic stem cells Abandoned AU3635695A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30902694A 1994-09-19 1994-09-19
US309026 1994-09-19
PCT/US1995/011892 WO1996009400A1 (en) 1994-09-19 1995-09-18 Methods for genetically modifying hematopoietic stem cells

Publications (1)

Publication Number Publication Date
AU3635695A true AU3635695A (en) 1996-04-09

Family

ID=23196354

Family Applications (1)

Application Number Title Priority Date Filing Date
AU36356/95A Abandoned AU3635695A (en) 1994-09-19 1995-09-18 Methods for genetically modifying hematopoietic stem cells

Country Status (2)

Country Link
AU (1) AU3635695A (en)
WO (1) WO1996009400A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5928638A (en) * 1996-06-17 1999-07-27 Systemix, Inc. Methods for gene transfer
EP0929664A1 (en) * 1996-09-23 1999-07-21 Ontogeny, Inc. Hematopoietic stem cells and methods for generating such cells
US6818209B1 (en) 1998-05-22 2004-11-16 Oxford Biomedica (Uk) Limited Retroviral delivery system
AU8105798A (en) * 1997-05-16 1998-12-11 Leuven Research & Development Vzw Mammalian cell transduction for use in gene therapy
EP0938904A1 (en) * 1998-02-09 1999-09-01 Leuven Research & Development vzw Mammalian cell transduction for use in gene therapy
CA2292760A1 (en) 1997-06-04 1998-12-10 Oxford Biomedica (Uk) Limited Vector
ATE435297T1 (en) * 1998-05-22 2009-07-15 Oxford Biomedica Ltd RETROVIRAL ADMINISTRATION SYSTEM
WO1999061644A1 (en) * 1998-05-29 1999-12-02 Case Western Reserve University Hematopoietic progenitor cell gene transduction
GB0009760D0 (en) 2000-04-19 2000-06-07 Oxford Biomedica Ltd Method
GB0024550D0 (en) 2000-10-06 2000-11-22 Oxford Biomedica Ltd
CA2344208A1 (en) 2001-04-30 2002-10-30 Oxford Biomedica (Uk) Limited Method
AUPR518501A0 (en) 2001-05-22 2001-06-14 Unisearch Limited Yin yang-1
SI1504108T1 (en) 2002-02-01 2013-07-31 Oxford Biomedica (Uk) Limited Lentiviral vector
WO2004098531A2 (en) * 2003-05-05 2004-11-18 Virxsys Corporation Increased transduction using abc transporter substrates and/or inhibitors
CA2606287A1 (en) 2005-05-13 2006-11-16 Oxford Biomedica (Uk) Limited Peptide
US9206440B2 (en) 2009-01-23 2015-12-08 Roger Williams Hospital Viral vectors encoding multiple highly homologus non-viral polypeptides and the use of same
EP2646107A2 (en) 2010-12-01 2013-10-09 Spinal Modulation Inc. Agent delivery systems for selective neuromodulation
GB201318804D0 (en) 2013-10-24 2013-12-11 Adaptimmune Ltd Vectors for transgene expression
DE102020111571A1 (en) 2020-03-11 2021-09-16 Immatics US, Inc. WPRE MUTANT CONSTRUCTS, COMPOSITIONS, AND RELATED PROCEDURES
DE102020106710A1 (en) 2020-03-11 2021-09-16 Immatics US, Inc. WPRE MUTANT CONSTRUCTS, COMPOSITIONS, AND RELATED PROCEDURES

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988008450A1 (en) * 1987-05-01 1988-11-03 Birdwell Finlayson Gene therapy for metabolite disorders
JP3547129B2 (en) * 1991-02-19 2004-07-28 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Virus particles with altered host range
WO1993014188A1 (en) * 1992-01-17 1993-07-22 The Regents Of The University Of Michigan Targeted virus
KR950700403A (en) * 1992-03-04 1995-01-16 죤 제이. 쉬바르츠 CULTURING OF HEMATOPOIETIC STEM CELLS AND THEIR GENETIC ENGINEERING
US5834256A (en) * 1993-06-11 1998-11-10 Cell Genesys, Inc. Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells

Also Published As

Publication number Publication date
WO1996009400A1 (en) 1996-03-28

Similar Documents

Publication Publication Date Title
AU3635695A (en) Methods for genetically modifying hematopoietic stem cells
AU8777898A (en) Methods for genetically modifying t cells
AU4754393A (en) Cell culture insert
EP0788165A3 (en) Storage cell arrangement and method for making the same
AU4758496A (en) Primate embryonic stem cells
AU6060394A (en) Stem cell factor
AU6988596A (en) Photovoltaic cell
AU2892295A (en) Stem cell immobilisation
AU5969296A (en) Chemically defined medium for human mesenchymal stem cells
AU7468896A (en) Novel chemokine for mobilizing stem cells
AU3395695A (en) Totipotent cells for nuclear transfer
AU3491195A (en) Genetically engineered cells that produce dopamine
AU670503B2 (en) Methods for assembling lead-acid batteries
AU1461895A (en) Embryonic stem cell isolation
AU5116596A (en) Cell culture method
AU9508998A (en) Methods and compositions for binding hematopoietic stem cells
AU3752293A (en) Photovoltaic cells
AU9732098A (en) Hematopoietic stem cells
AU4317597A (en) Hematopoietic stem cells and methods for generating such cells
AU7082694A (en) Hematopoietic stem cell proliferation accelerator
AU4030997A (en) Hematopoietic stem cell growth factor (scgf)
AU2616095A (en) Method for introducing foreign matter into higher eukaryotic cells
AU8808798A (en) Method for the ex-vivo expansion of hematopoietic stem cells
AU1685895A (en) Hematopoietic cell expansion and transplantation methods
AU6083898A (en) Method for the manufacture of photovoltaic cell